What Does FDA Think of AI?

Speaking at CES 2024 earlier this year, U.S. Food and Drug Administration (FDA) Commissioner Robert Califf expressed significant concerns about the FDA’s ability to effectively regulate artificial intelligence (AI) in the healthcare sector. While acknowledging that AI presents significant opportunities in terms of both improving patient outcomes and giving doctors and nurses more time to devote to patient care, he also stressed that effective regulation is going to be essential in the years to…
By: Gardner Law